A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis
Phase of Trial: Phase III
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 06 Jun 2017 Trial phase has been change from phase 4 to phase 3 .
- 06 Jun 2017 Planned number of patients changed from 90 to 112.
- 22 May 2017 Planned End Date changed from 8 Dec 2017 to 18 Oct 2017.